2ooz

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2ooz.jpg|left|200px]]
[[Image:2ooz.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2ooz |SIZE=350|CAPTION= <scene name='initialview01'>2ooz</scene>, resolution 1.8&Aring;
+
The line below this paragraph, containing "STRUCTURE_2ooz", creates the "Structure Box" on the page.
-
|SITE= <scene name='pdbsite=AC1:So4+Binding+Site+For+Residue+A+901'>AC1</scene>, <scene name='pdbsite=AC2:So4+Binding+Site+For+Residue+B+902'>AC2</scene>, <scene name='pdbsite=AC3:So4+Binding+Site+For+Residue+C+903'>AC3</scene>, <scene name='pdbsite=AC4:So4+Binding+Site+For+Residue+A+904'>AC4</scene>, <scene name='pdbsite=AC5:So4+Binding+Site+For+Residue+B+905'>AC5</scene>, <scene name='pdbsite=AC6:Ox5+Binding+Site+For+Residue+A+200'>AC6</scene>, <scene name='pdbsite=AC7:Ox5+Binding+Site+For+Residue+B+200'>AC7</scene>, <scene name='pdbsite=AC8:Gol+Binding+Site+For+Residue+A+701'>AC8</scene>, <scene name='pdbsite=AC9:Gol+Binding+Site+For+Residue+B+702'>AC9</scene>, <scene name='pdbsite=BC1:Gol+Binding+Site+For+Residue+C+703'>BC1</scene> and <scene name='pdbsite=BC2:Ipa+Binding+Site+For+Residue+A+801'>BC2</scene>
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=IPA:ISOPROPYL+ALCOHOL'>IPA</scene>, <scene name='pdbligand=OX5:4-HYDROXYBENZALDEHYDE+O-(3,3-DIMETHYLBUTANOYL)OXIME'>OX5</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Phenylpyruvate_tautomerase Phenylpyruvate tautomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.3.2.1 5.3.2.1] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE= MIF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2ooz| PDB=2ooz | SCENE= }}
-
|RELATEDENTRY=[[2ooh|2OOH]], [[2oow|2OOW]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2ooz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2ooz OCA], [http://www.ebi.ac.uk/pdbsum/2ooz PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2ooz RCSB]</span>
+
-
}}
+
'''Macrophage Migration Inhibitory Factor (MIF) Complexed with OXIM6 (an OXIM Derivative Not Containing a Ring in its R-group)'''
'''Macrophage Migration Inhibitory Factor (MIF) Complexed with OXIM6 (an OXIM Derivative Not Containing a Ring in its R-group)'''
Line 32: Line 29:
[[Category: Crichlow, G V.]]
[[Category: Crichlow, G V.]]
[[Category: Lolis, E.]]
[[Category: Lolis, E.]]
-
[[Category: alternative ligand-binding mode]]
+
[[Category: Alternative ligand-binding mode]]
-
[[Category: isomerase]]
+
[[Category: Isomerase]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 11:21:28 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:20:59 2008''
+

Revision as of 08:21, 4 May 2008

Image:2ooz.jpg

Template:STRUCTURE 2ooz

Macrophage Migration Inhibitory Factor (MIF) Complexed with OXIM6 (an OXIM Derivative Not Containing a Ring in its R-group)


Contents

Overview

Pharmacophores are chemical scaffolds upon which changes in chemical moieties (R-groups) at specific sites are made to identify a combination of R-groups that increases the therapeutic potency of a small molecule inhibitor while minimizing adverse effects. We developed a pharmacophore based on a carbonyloxime (OXIM) scaffold for macrophage migration inhibitory factor (MIF), a protein involved in the pathology of sepsis, to validate that inhibition of a catalytic site could produce therapeutic benefits. We studied the crystal structures of MIF.OXIM-based inhibitors and found two opposite orientations for binding to the active site that were dependent on the chemical structures of an R-group. One orientation was completely unexpected based on previous studies with hydroxyphenylpyruvate and (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1). We further confirmed that the unexpected binding mode targets MIF in cellular studies by showing that one compound, OXIM-11, abolished the counter-regulatory activity of MIF on anti-inflammatory glucocorticoid action. OXIM-11 treatment of mice, initiated 24 h after the onset of cecal ligation and puncture-induced sepsis, significantly improved survival when compared with vehicle-treated controls, confirming that inhibition of the MIF catalytic site could produce therapeutic effects. The crystal structures of the MIF inhibitor complexes provide insight for further structure-based drug design efforts.

Disease

Known disease associated with this structure: Persistent Mullerian duct syndrome, type I OMIM:[600957], Rheumatoid arthritis, systemic juvenile, susceptibility to OMIM:[153620]

About this Structure

2OOZ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor., Crichlow GV, Cheng KF, Dabideen D, Ochani M, Aljabari B, Pavlov VA, Miller EJ, Lolis E, Al-Abed Y, J Biol Chem. 2007 Aug 10;282(32):23089-95. Epub 2007 May 25. PMID:17526494 Page seeded by OCA on Sun May 4 11:21:28 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2ooz"
Personal tools